Atlas Trials

Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis

Clinical trial NCT01214564 · COMPLETED

Trial details

NCT number
NCT01214564
Sponsor
Peplin
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Seborrheic Keratosis
Start date
2010-10-01
Primary completion
2010-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.